Empirically Establishing Blood Glucose Targets to Achieve HbA1c Goals
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the average fasting, postprandial, and bedtime self-monitored blood glucose (SMBG) concentrations associated with specified HbA1c levels using data from the A1c-Derived Average Glucose (ADAG) study. RESEARCH DESIGN AND METHODS: The ADAG study was a multicenter observational study that used continuous glucose monitoring and SMBG testing to determine the relationship between mean average glucose and HbA1c. We used the SMBG data from 470 of the ADAG study participants (237 with type 1 diabetes and 147 with type 2 diabetes) to determine the average fasting, premeal, 90-min postmeal, and bedtime blood glucose (BG) for predefined target HbA1c groups between 5.5 and 8.5% (37–69 mmol/mol). t Tests were used to compare mean BG values between type 1 and type 2 diabetes groups. RESULTS: The average fasting BG needed to achieve predefined HbA1c target levels of 5.5–6.49% (37–47 mmol/mol), 6.5–6.99% (48–52 mmol/mol), 7.0–7.49% (52–58 mmol/mol), 7.5–7.99% (58–64 mmol/mol), and 8.0–8.5% (64–69 mmol/mol) were 122 mg/dL with 95% CI 117–127, 142 mg/dL (135–150), 152 mg/dL (143–162), 167 mg/dL (157–177), and 178 mg/dL (164–192), respectively. Postmeal BG to achieve the HbA1c level of 6.5–6.99% (48–52 mmol/mol) and 7.0–7.49% (52–58 mmol/mol) were 164 mg/dL (159–169) and 176 mg/dL (170–183), respectively. Bedtime BG was 153 mg/dL (145–161) and 177 mg/dL (166–188), respectively. CONCLUSIONS: We have determined the average BG at premeal, postmeal, and bedtime to achieve a variety of HbA1c targets. These results, based on empirical data, will help patients and providers set realistic day-to-day SMBG targets to achieve individualized HbA1c goals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These data prompted the revision in the ADArecommended premeal glucose target to 80-130 mg/dL (4.4-7.2 mmol/L) but did not affect the definition of hypoglycemia.”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This change reflects the results of the ADAG study, which demonstrated that higher glycemic targets corresponded to A1C goals ( 14).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ADAG study assessed the correlation between A1C and frequent BGM and CGM in 507 adults (83% non-Hispanic White) with type 1, type 2, and no diabetes (19,20).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The correlation between A1C and average glucose was 0.92 (19,20).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A1C measurement encompasses a component of both the FPG and postprandial PG.”
From Targets for Glycemic Control (2018) · cites this paper as [35]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Self-citationAuthors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Long-Term Complications of Diabetes Mellitus
Nathan, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282306 · Cited by 1,495
Self-citationGlobal guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases: Executive Summary
Rydén, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., De Boer, M.-J., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60205-9 · Cited by 242
Cobin, R. H., Futterweit, W., Ginzburg, S. B., Goodman, N. F., Kleerekoper, M., Licata, A. A., Meikle, A. W., Petak, S. M., Porte, K. L., Sellin, R. V., et al. (2006) · Endocrine Practice · doi:10.4158/ep.12.3.315 · Cited by 185
Standards of Care for Diabetes
Weir, G. C., Nathan, D. M., & Singer, D. E. (1994) · Diabetes Care · doi:10.2337/diacare.17.12.1514 · Cited by 59
Self-citationThe Parathyroid Glands: What The Endocrine Surgeon Should Know
Perrier, N. D. (2011) · Endocrine Practice · doi:10.4158/ep11007.co · Cited by 45
Cited by
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
6. Glycemic Targets: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s006 · Cited by 762
6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744
6. Glycemic Targets: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s006 · Cited by 684
6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s006 · Cited by 655
Chamberlain, J. J., Rhinehart, A. S., Shaefer, C. F., & Neuman, A. (2016) · Annals of Internal Medicine · doi:10.7326/m15-3016 · Cited by 631
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 486
The relationship of hemoglobin A1C to time-in-range in patients with diabetes
Vigersky, R. A., & McMahon, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0310 · Cited by 464
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Diabetes: Advances in Diagnosis and Treatment
Nathan, D. M. (2015) · JAMA · doi:10.1001/jama.2015.9536 · Cited by 384
Self-citationFlood, D., Seiglie, J. A., Dunn, M., Tschida, S., Theilmann, M., Marcus, M. E., Brian, G., Norov, B., Mayige, M. T., Gurung, M. S., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00089-1 · Cited by 277
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s009 · Cited by 271
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s008 · Cited by 215
“Due to variable adherence, optimal CGMuse requires an assessment of individual readiness for the technology as well as initial and ongoing education andsupport (16,24).”
BackgroundMethodResultInfluentialAmerican Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s009 · Cited by 205
US Emergency Department Visits Attributed to Medication Harms, 2017-2019
Budnitz, D. S., Shehab, N., Lovegrove, M. C., Geller, A. I., Lind, J. N., & Pollock, D. A. (2021) · JAMA · doi:10.1001/jama.2021.13844 · Cited by 178
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
Imran, S. A., Agarwal, G., Bajaj, H. S., & Ross, S. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.030 · Cited by 113
Treatment of type 2 diabetes mellitus in the elderly
Yakaryılmaz, F. D., & Öztürk, Z. A. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.278 · Cited by 135
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
2023 Guidelines on the management of patients with diabetes - a position of Diabetes Poland
Araszkiewicz, A., Bandurska-Stankiewicz, E. M., Borys, S., Budzynski, A. Z., Cyganek, K., Cypryk, K., Czech, A., Czupryniak, L., Drzewoski, J., Dzida, G. J., et al. (2023) · Current Topics in Diabetes · doi:10.5114/ctd/160061 · Cited by 85
Chamberlain, J. J., Kalyani, R. R., Leal, S., Rhinehart, A. S., Shubrook, J. H., Skolnik, N., & Herman, W. H. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1259 · Cited by 61
Shewade, H. D., Jeyashree, K., Mahajan, P. B., Shah, A. N., Kirubakaran, R., Rao, R., & Kumar, A. M. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186697 · Cited by 69
Kim, J., & Hur, M.-H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168439 · Cited by 51
“HbA1c, an important indicator of glycemic control, is closely correlated with average blood sugar levels in diabetes patients, and it is also an indicator for the reduced risk of complications [12,13].”
BackgroundType 1 diabetes in adults: supporting self management
Reddy, M., Rilstone, S., Cooper, P., & Oliver, N. S. (2016) · BMJ · doi:10.1136/bmj.i998 · Cited by 47
The many faces of diabetes. Is there a need for re-classification? A narrative review
Sakran, N., Graham, Y. N. H., Pintar, T., Yang, W., Kassir, R., Willigendael, E. M., Singhal, R., Kooreman, Z. E., Ramnarain, D., Mahawar, K. K., et al. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00927-y · Cited by 55
“The A1C goal should be set somewhat higher (< 8% or higher) for patients with a history of severe hypoglycemia, patients with limited life expectancy, very young children or older adults, and individuals with advanced complications or comorbid conditions [7, 32].”
BackgroundGlycemic variability: Importance, relationship with physical activity, and the influence of exercise
Sparks, J. R., Kishman, E. E., Sarzynski, M. A., Davis, J. M., Grandjean, P. W., Durstine, J. L., & Wang, X. (2021) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2021.09.004 · Cited by 51
Gomez-Peralta, F., Escalada San Martín, F. J., Menéndez Torre, E., Mata Cases, M., Ferrer García, J. C., Ezkurra Loiola, P., Ávila Lachica, L., Fornos Pérez, J. A., Artola Menéndez, S., Álvarez-Guisasola, F., et al. (2018) · Endocrinología, Diabetes y Nutrición · doi:10.1016/j.endinu.2018.08.004 · Cited by 39
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 84
Boye, A., Acheampong, D. O., Ofori, E. G., Asiamah, E. A., Addo, J. K., Mensah, D. A., Brah, A. S., & Ayiku, P. J. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112918 · Cited by 46
Litchfield, I. J., Andrews, R. C., Narendran, P., & Greenfield, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00076 · Cited by 43
Assulyn, T., Khamisy‐Farah, R., Nseir, W., Bashkin, A., & Farah, R. E. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23259 · Cited by 35
Østergaard, H. B., Mandrup-Poulsen, T. R., Berkelmans, G. F. N., van der Graaf, Y., Visseren, F. L. J., & Westerink, J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.04.006 · Cited by 33
Gore, M. O., & McGuire, D. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.070 · Cited by 33
Forst, T. M., Choudhary, P., Schneider, D., Linetzky, B., & Pozzilli, P. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3418 · Cited by 34
“…(118–127) 139 (139–147) 147 (133–161) 157 (139–176) 179 (158–201) Abbreviations: CI, confidence interval; FPG, fasting plasma glucose; HbA1c, haemoglobin A1c. aModified from Wei et al., 2014.94 (5.6 mmol/L)37 based on the ‘Treat‐to‐Target’ paradigm of dose adjustments to make insulin therapy…”
MethodInfluentialSetty, S. G., Crasto, W., Jarvis, J., Khunti, K., & Davies, M. J. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133716 · Cited by 37
Afsharian, S., Akbarpour, S., Abdi, H., Sheikholeslami, F. H., Moeini, A. S. H., Khalili, D., Momenan, A. A., Azizi, F., & Hadaegh, F. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2776 · Cited by 31
“Our study has some limitations; first, we had no information regarding A1c level in our population and used FPG as surrogate of A1c; second, the statistical power of our study was 97 and 87% to detect a HR of 60% for cardiovascular disease and all-causemortality events, respectively, and also 58 and 41% to detect a HR…”
MethodInfluentialKilonzo, S. B., Gunda, D. W., Bakshi, F. A., Kalokola, F., Mayala, H. A., & Dadi, H. K. (2017) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v27i5.5 · Cited by 27
“Patients were labeled to have poor glycemic control when average FBG was >7.0mmol/L. Glycosylated hemoglobin (HbA1C) was not done in these patients.”
MethodInfluentialCheng, W., Huang, R., Pu, Y., Li, T., Bao, X., Chen, J., Li, G., Wu, H., & Wei, Z. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2330615 · Cited by 27
“…glycosylated haemoglobin, which is the gold standard for monitoring glycaemic control, and blood glucose levels, this is not always the case [23]. the determination of hba1c is based on the assumption that the glucose concentration in red blood cells is equal to the plasma glucose…”
BackgroundTaniguchi, D., LoGerfo, J. P., van Pelt, M. H., Mielcarek, B., Huster, K., Haider, M. Z., & Thomas, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181582 · Cited by 26
Grady, M., Cameron, H., Levy, B. L., & Katz, L. B. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815622646 · Cited by 28
“Methods: Subjects with T1DM (23) or T2DM (17) uploaded BG meter results to OTR for 12 weeks.”
MethodKlonoff, D. C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814529638 · Cited by 21
“A new analysis of the ADAG (A1C-derived average glucose) Study Group report that was published in 2008 empirically links target blood glucose values with A1C levels.(1) This is a major advance for clinicians who will now be able to assign target self-monitored blood glucose values according to patients’ intended level…”
BackgroundMethodInfluentialPontes, J. P. J., Mendes, F. F., Vasconcelos, M. M., & Batista, N. R. (2017) · Brazilian Journal of Anesthesiology · doi:10.1016/j.bjan.2017.04.017 · Cited by 30
Estimating HbA1c from timed Self-Monitored Blood Glucose values
Fan, W., Zheng, H., Wei, N., & Nathan, D. M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.023 · Cited by 19
Self-citationA Perspective on the Accuracy of Blood Glucose Meters During Pregnancy
Immanuel, J., & Simmons, D. S. (2018) · Diabetes Care · doi:10.2337/dc18-0833 · Cited by 18
Standards of Care in Diabetes. The position of Diabetes Poland – 2024
Araszkiewicz, A., Bandurska-Stankiewicz, E. M., Borys, S., Broncel, M., Budzynski, A. Z., Cyganek, K., Cypryk, K., CYRANKA, K. M., Czupryniak, L., Dzida, G. J., et al. (2024) · Current Topics in Diabetes · doi:10.5114/ctd/183052 · Cited by 33
Rathmann, W., Bongaerts, B. W. C., & Kostev, K. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12823 · Cited by 19
“Recent guidelines for the management of hyperglycemia in people with type 2 diabetes mellitus (T2DM) state that glycemic targets should be individualized using a patient-centered approach, for example by taking into account age, duration of diabetes, and comorbidity.1 Target goals are mostly defined for HbA1c, but to…”
BackgroundMethodInfluentialGrady, M., Warren, G., Levy, B. L., & Katz, L. B. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815569882 · Cited by 17
Takao, T., Inoue, K., Suka, M., Yanagisawa, H., & Iwamoto, Y. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.051 · Cited by 18
Pontes, J. P. J., Mendes, F. F., Vasconcelos, M. M., & Batista, N. R. (2017) · Brazilian Journal of Anesthesiology (English Edition) · doi:10.1016/j.bjane.2017.06.002 · Cited by 20
Peralta, F. G., Martín, F. J. E. S., Torre, E. L. M., Mata‐Cases, M., García, J. C. F., Loiola, P. E., Lachica, L. Á., Pérez, J. A. F., Menéndez, S. A., Guisasola, F. Á., et al. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.11.010 · Cited by 20
Quality of life and metabolic control in type 2 diabetes mellitus diagnosed individuals
Cepeda, J., Ruíz-Matuk, C. B., Mota, M., Pérez, S., Recio, N., Hernández, D., Fernández, J., Porto, J., & Ramos, A. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.062 · Cited by 16
Paing, A. C., McMillan, K. A., Kirk, A. F., Collier, A., Hewitt, A., & CHASTIN, S. F. M. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04261-z · Cited by 19
Paing, A. C., McMillan, K. A., Kirk, A. F., Collier, A., Hewitt, A., Dunstan, D. W., Owen, N. G., & CHASTIN, S. F. M. (2020) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2020.06.003 · Cited by 18
Zivkovic, J., Mitter, M., Theodorou, D., Kober, J., Mueller-Hoffmann, W., & MIKULSKI, H. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0169 · Cited by 16
“19 Good control is often de fi ned as an HbA1c level 7%, which correlates with an average blood glucose (BG) level of 154 mg/dL. 20,21 Understanding glucose levels and overall glycemic con-trol, regardless of the diabetes type, is an integral component of diabetes management.”
Sivasubramaniyam, S., Amiel, S. A., & Choudhary, P. (2017) · Diabetic Medicine · doi:10.1111/dme.13438 · Cited by 12
Morea, N., Retnakaran, R. R., Vidal, J., Aroda, V. R., Liu, M., Saremi, A., & Giorgino, F. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14077 · Cited by 12
Elsherif, I., Jammah, A. A., Ibrahim, A. R., Alawadi, F., Sadek, I. S., Rahman, A. M., Sharify, G. E., AlFeky, A., Aldossari, K. K., Roushdy, E., et al. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.06.003 · Cited by 11
Hong, S., Kang, J. G., Kim, C. S., Lee, S. J., Lee, C. B., & Ihm, S. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0179-8 · Cited by 12
“These results showed that mean FPG concentrations for specified A1C levels in this study were lower than those in previous western studies [12, 13] (Table 3).”
BackgroundResultUnleashing the Potential of Blood Glucose Monitoring Data With the Ambulatory Glucose Profile Report
Simonson, G. D., Holt, E. H., Grady, M., Hurrell, G., Gaudiani, L., & Bergenstal, R. M. (2024) · Clinical Diabetes · doi:10.2337/cd23-0092 · Cited by 11
Chung, G. S., Si, Y., Aryal, K., Bahendeka, S., Banegas, J. R., Bärnighausen, T., Barreto, M., Basit, A., Bello‐Chavolla, O. Y., Bovet, P., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00393-6 · Cited by 11
Chawla, R., Mukherjee, J. J., Chawla, M. S., Kanungo, A. K., Shunmugavelu, M., & Das, A. K. (2021) · Medical Sciences · doi:10.3390/medsci9020038 · Cited by 10
Quigley, M., Earnest, A., Szwarcbard, N., Wischer, N., Andrikopoulos, S., Green, S., & Zoungas, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263511 · Cited by 7
Management of Type 2 Diabetes Mellitus
Dungan, K. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00048-2 · Cited by 10
Getting to goal in newly diagnosed type 2 diabetes using combination drug “subtraction therapy”
Jennings, A. S., Lovett, A. J., George, T. M., & Jennings, J. S. (2015) · Metabolism · doi:10.1016/j.metabol.2015.04.008 · Cited by 7
“Most pathways are unproven, especially over an extended period of treatment, and eventually lead to insulin therapy [2–5].”
Background‘Knowing where I am’: self-monitoring of blood glucose in diabetes
Meetoo, D. D., Wong, L., & Fatani, T. (2018) · British Journal of Nursing · doi:10.12968/bjon.2018.27.10.537 · Cited by 8
Wu, Y., Zhang, B., Ma, X., Yu, P., Zhou, S., & Wang, X. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01591-1 · Cited by 5
Shewade, H. D., Ravichandran, P., Satish, S., Pradeep, S. K., Jeyashree, K., Mahajan, P. B., Shah, A. N., Kirubakaran, R., & Kumar, A. M. V. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328619 · Cited by 4
“If three or more cFBG values are available during treatment, considering conversion of mean cFBG during treatment to an estimated HbA1c during treatment [42,43] 7.”
A Case of Inappropriately High Glycated Hemoglobin
Lodh, M., Mukhopadhyay, R., & Kumar, B. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0460-2 · Cited by 4
“The estimated glucose levels [4] did not correlate with the actual plasma glucose of the patient.”
BackgroundKalweit, K., Zyl, D. G. V., & Rheeder, P. (2018) · South African Medical Journal · doi:10.7196/samj.2018.v108i8.12801 · Cited by 5
Walicka, M., Jozwiak, J. J., Rzeszotarski, J., Zonenberg, A., Masierek, M., Bijoś, P., & Franek, E. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0570-1 · Cited by 4
MATUS, A. M., Trout, K. K., Sawyer, A. M., & Riegel, B. J. (2021) · Journal of Advanced Nursing · doi:10.1111/jan.14947 · Cited by 4
Özışık, H., Çetinkalp, Ş., Süner, A., Özgen, G., Saygılı, F., & Erdoğan, M. (2022) · Ege Tıp Dergisi · doi:10.19161/etd.1168234 · Cited by 3
Alchujyan, N., Hovhannisyan, M., Movsesyan, N., Melkonyan, A., Shaboyan, V., Aghajanova, E., Minasyan, G. H., & Kevorkian, G. A. (2021) · Endocrine Research · doi:10.1080/07435800.2021.1920608 · Cited by 3
“of hypoglycemia, to which young children with T1DM are especially vulnerable.(32) In our study, plasma HbA1c concentration below 7.”
BackgroundTorjman, M. C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816667748 · Cited by 3
Bloomgarden, Z. T., & Handelsman, Y. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12152 · Cited by 3
“0%).(11) Furthermore, insulin treatment certainly leads to hypoglycemia and weight gain,(12,13) and it is often the case that once a patient’s fasting glucose level nears 7 mmol/L (126 mg/dl) there may be considerable increase in insulin dosage for relatively little further improvement in glycemia.”
BackgroundXiao, Z., Yin, X., Lai, X., Zhou, X., Zhang, Y., Yang, D., Wu, R., Wang, H., Zhou, J., Yang, X., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1648314 · Cited by 2
Short bouts of hypoxia improve insulin sensitivity in adults with type 2 diabetes
Zhao, J., Massoudian, S. D., Stray-Gundersen, S. O., Wojan, F., & Lalande, S. (2025) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00932.2024 · Cited by 2
The Association between Bariatric Surgery Outcomes and Socioeconomic Deprivation
Jomon, M., Lucocq, J. E., Geropoulos, G., de Beaux, A. C., Tulloh, B. R., Joyce, B., Wallace, B., Drummond, G., Lamb, P., & Robertson, A. G. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07747-2 · Cited by 2
“Resolution was defined as the cessation of treatment for the relevant condition with normalisation of physiological parameters (e.g. returning to normal blood pressure or an HbA1c of less than 48 mmol/ mol) [14].”
Unexpected high HbA1c results due to an unusual haemoglobin variant: an important clinical lesson
Floyd, C. N., Brady, S. F., Monteiro, D., Nathan, Y., & Crook, M. A. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-139459 · Cited by 2
Zare, M., Tarrahi, M. J., Sadeghi, O., Karimifar, M., Goli, S. A. H., & Amani, R. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70577 · Cited by 2
“Participants were included in the study if their fasting blood glucose was less than 150 mg/dL at the first visit (Wei et al. 2014).”
Hemoglobin A1c in the ESRD Population: Status Report
Williams, M. E. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12276 · Cited by 2
“However, many patients also have low PTH levels (3) which may also be associated with the adynamic bone disease (ABD) (4,5) and increased mortality (6).”
BackgroundDiabetes Mellitus type 2: Management and follow up in Primary Health Care Center
Alkinani, A. A., Alkhrizi, I. M., Alkathiri, S. H., Alzubaidi, H. L. A., Alghanmi, A. A., Alghanmi, A. M., Alnashri, I. A., & Alruwaili Amal Muhaysin, B. (2021) · Archives of Pharmacy Practice · doi:10.51847/mvmt9sdifp · Cited by 4
The Role of Hemoglobin A1C in Diabetes Screening and Diabetic Retinopathy
Villacreses, M. M. C., Karnchanasorn, R., Ou, H., Samoa, R. A., Chuang, L., & Chiu, K. C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214947 · Cited by 1
“From the A1C-Derived Average Glucose study [26,27] based on 470 diabetic patients, mean fasting glucose was 7.”
MethodLi, A., Li, X., Geng, Z., Zhang, J., Wang, X., & Tang, F. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0381 · Cited by 1
Teufel, F., Theilmann, M., Marcus, M. E., Sulola, M. A., Guwatudde, D., Quintana, H. K., Banegas, J. R., Soniwala, A., Kim, S., Aryal, K., et al. (2026) · Diabetes Care · doi:10.2337/dc26-0267 · Cited by 1
Elamin, A., & Teckchandani, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-6406-8_24 · Cited by 1
Effective Diabetes Self-Management Education: Focus on Blood Glucose Pattern Management
Sim, K. H. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.1.35 · Cited by 1
“미국당뇨병학회에서는 공복혈 당 목표를 80~130 mg/dL, 식후혈당 < 180 mg/dL로 권고 하였다[7].”
Nah, E., Cho, S., Park, H., Noh, D., Kwon, E., & Cho, H. (2022) · Healthcare · doi:10.3390/healthcare10050824 · Cited by 2
“[27] calculated average glucose concentrations using only the blood glucose values collected by SMBG for specified ranges of HbA1c values obtained from subjects in the ADAG study.”
MethodInsulinothérapie basale chez les patients diabétiques de type 2
Vuignier, Y., Roukain, A., Kosinski, C., & Wojtusciszyn, A. (2021) · JMIG · doi:10.53738/revmed.2021.17.741.1078
Type 2 diabetes: glycaemic control
FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch10
Mezitis, N. H. E., & Mezitis, S. G. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_39
FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch4
Mezitis, N. H. E., & Mezitis, S. G. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_39-1
Type 1 diabetes: glycaemic control
FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch7
Intelligent agent design for persuading the elderly to adopt a healthy lifestyle
Yu, X. (2021) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/159204
Todo lo que usted quiso saber sobre la monitorización de la glucosa y nunca se atrevió a preguntar
Guijarro, J. M. B., & Cuenca, A. M. C. (2022) · Diabetes práctica · doi:10.52102/diabet/pract/2022.3/art2
MESA 2: INNOVACIONES TECNOLÓGICAS EN EL TRATAMIENTO DE LA DIABETES MELLITUS TIPO 1
Morosini, M. L. R., PROIETTI, A. E., Ré, M., Schindler, A., Medek, G., Dios, A. D., Larreburo, S. V., Mengoni, K., González, L. S., Méndez, J., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v49i3.634
English, E. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch29 · Cited by 1
Deaver, J. E., Uchuya, G. M., Cohen, W. R., & Foote, J. A. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003512
Metadata
- Authors
- Wei, N., Zheng, H., & Nathan, D. M.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Wei, Nancy
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-03-08
- Volume
- 37
- Issue
- 4
- Pages
- 1048-1051
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3964488
- OpenAlex
- W2164296416
- Semantic Scholar
- d8a376fcd735a402e761b036415cb469049f4d80
- Cited by
- 105
- References
- 10
- Citations by year
- 2026: 1 · 2025: 11 · 2024: 13 · 2023: 4 · 2022: 6 · 2021: 13 · 2020: 6 · 2019: 5 · 2018: 12 · 2017: 13 · 2016: 9 · 2015: 7 · 2014: 5
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-06-01)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007028)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, HbA1c, glycemic control, type 1 diabetes, type 2 diabetes, self-monitoring of blood glucose, fasting blood glucose, postprandial blood glucose, continuous glucose monitoring, glycemic variability
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Fasting, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Blood Glucose Self-Monitoring, Postprandial Period, Empirical Research, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.